King's College London

Research portal

Drug Safety, 0114-5916

Journal

  1. Pharmaceutical Benefit–Risk Perception and Age Differences in the USA and Germany

    Balog-Way, D. H. P., Evensen, D. & Löfstedt, R. E., 1 Nov 2020, In : Drug Safety. 43, 11, p. 1141-1156 16 p.

    Research output: Contribution to journalArticle

  2. Thromboembolism and Janus Kinase Inhibitors

    Ibrahim, F. & Scott, D. L., 1 Sep 2020, In : Drug Safety. 43, 9, p. 831-833 3 p.

    Research output: Contribution to journalComment/debate

  3. Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab

    Jackson, D. J., Korn, S., Mathur, S. K., Barker, P., Meka, V. G., Martin, U. J. & Zangrilli, J. G., 1 May 2020, In : Drug Safety. 43, 5, p. 409-425 17 p.

    Research output: Contribution to journalReview article

  4. Frailty and Drug Safety at Older Ages

    Gulliford, M., 4 Jun 2019, In : Drug Safety. 42, 6, p. 699-700 2 p.

    Research output: Contribution to journalComment/debate

  5. Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed

    Jacobson, G. A., Raidal, S., Hostrup, M., Calzetta, L., Wood-Baker, R., Farber, M. O., Page, C. P. & Walters, E. H., 1 May 2018, In : Drug Safety. 41, 5, p. 441-449 9 p.

    Research output: Contribution to journalArticle

  6. Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature

    Way, D., Blazsin, H., Lofstedt, R. & Bouder, F., 14 Oct 2016, In : Drug Safety. p. 1-22 22 p.

    Research output: Contribution to journalArticle

  7. Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record Data

    Sauzet, O., Carvajal, A., Escudero, A., Molokhia, M. & Cornelius, V. R., 1 Oct 2013, In : Drug Safety. 36, 10, p. 995-1006 12 p., N/A.

    Research output: Contribution to journalArticle

  8. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Are Drug Dictionaries Correctly Informing Physicians Regarding the Risk?

    Haddad, C., Sidoroff, A., Kardaun, S. H., Mockenhaupt, M., Creamer, D., Dunant, A. & Roujeau, J-C., Aug 2013, In : Drug Safety. 36, 8, p. 681-686 6 p.

    Research output: Contribution to journalArticle

  9. Neuropsychiatric events with varenicline: a modified prescription-event monitoring study in general practice in England

    Buggy, Y., Cornelius, V., Fogg, C., Kasliwal, R., Layton, D. & Shakir, S. A. W., Jul 2013, In : Drug Safety. 36, 7, p. 521-31 11 p.

    Research output: Contribution to journalArticle

  10. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme

    Hazell, L., Cornelius, V., Hannaford, P., Shakir, S., Avery, A. J. & Yellow Card Study Collaboration, Mar 2013, In : Drug Safety. 36, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  11. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases

    Coloma, P. M., Avillach, P., Salvo, F., Schuemie, M. J., Ferrajolo, C., Pariente, A., Fourrier-Réglat, A., Molokhia, M., Patadia, V., van der Lei, J., Sturkenboom, M. & Trifirò, G., Jan 2013, In : Drug Safety. 36, 1, p. 13-23 11 p.

    Research output: Contribution to journalArticle

  12. Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study

    Rashed, A. N., Wong, I. C. K., Cranswick, N., Hefele, B., Tomlin, S., Jackman, J., Lee, K., Hon, K-L. E., Ong, J., Ghaleb, M., Chua, S. S., Hui, T. M., Rascher, W. & Neubert, A., 1 Jun 2012, In : Drug Safety. 35, 6, p. 481-94 14 p.

    Research output: Contribution to journalArticle

  13. A Signal Detection Method to Detect Adverse Drug Reactions Using a Parametric Time-to-Event Model in Simulated Cohort Data

    Cornelius, V. R., Sauzet, O. & Evans, S. J. W., 2012, In : Drug Safety. 35, 7, p. 599-610 12 p.

    Research output: Contribution to journalArticle

  14. An Evaluation of the Evidence of an Association between Montelukast and Suicide: A Publicity Exacerbated Signal?

    Iessa, N., Star, K., Murray, M. L., Wilton, L., Curran, S., Edwards, R., Aronson, J. K., Besag, F., Santosh, P. & Wong, I. C. K., 2012, In : Drug Safety. 35, 10, p. 901-901 1 p.

    Research output: Contribution to journalMeeting abstract

  15. Risk of Depressive Episodes with Rimonabant

    Buggy, Y., Cornelius, V., Wilton, L. & Shakir, S. A. W., Jun 2011, In : Drug Safety. 34, 6, p. 501-509 9 p.

    Research output: Contribution to journalArticle

  16. Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs A Retrospective Cohort Study using the UK General Practice Research Database

    Ackers, R., Besag, F. M. C., Hughes, E., Squier, W., Murray, M. L. & Wong, I. C. K., May 2011, In : Drug Safety. 34, 5, p. 403-413 11 p.

    Research output: Contribution to journalArticle

  17. Mammalian Target of Rapamycin (mTOR) Inhibitors: Potential Uses and a Review of Haematological Adverse Effects

    Sofroniadou, S. & Goldsmith, D., Feb 2011, In : Drug Safety. 34, 2, p. 97-115 19 p.

    Research output: Contribution to journalLiterature review

  18. Hypoglycaemia with Oral Antidiabetic Drugs: Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide

    Vlckova, V., Cornelius, V., Kasliwal, R., Wilton, L. & Shakir, S. A. W., 2009, In : Drug Safety. 32, 5, p. 409-418 10 p.

    Research output: Contribution to journalArticle

  19. Poisons centres and the reporting of adverse drug events - The case for further development

    Volans, G. N., Karalliedde, L. & Wiseman, H. M., 2007, In : Drug Safety. 30, 3, p. 191 - 194 4 p.

    Research output: Contribution to journalEditorial

  20. Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients

    Kasliwal, R., Wilton, L. V., Cornelius, V., Aurich-Barrera, B. & Shakir, S. A. W., 2007, In : Drug Safety. 30, 2, p. 157-70 14 p.

    Research output: Contribution to journalArticle

  21. Safety profile of rosuvastatin - Results of a prescription-event monitoring study of 11680 patients

    Kasliwal, R., Wilton, L. V., Cornelius, V., Aurich-Barrera, B. & Shakir, S. A. W., 2007, In : Drug Safety. 30, 2, p. 157-170 14 p.

    Research output: Contribution to journalArticle

  22. Thiazolidinedi ones and their fluid-related adverse effects - Facts, fiction and putative management strategies

    Karalliedde, J. & Buckingham, R. E., 2007, In : Drug Safety. 30, 9, p. 741 - 753 13 p.

    Research output: Contribution to journalArticle

  23. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England

    Layton, D., Wilton, L., Boshier, A., Cornelius, V., Harris, S. & Shakir, S. A. W., 2006, In : Drug Safety. 29, 10, p. 897-909 13 p.

    Research output: Contribution to journalArticle

  24. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine - A prescription-event monitoring study in England

    Layton, D., Wilton, L., Boshier, A., Cornelius, V., Harris, S. & Shakir, S. A. W., 2006, In : Drug Safety. 29, 10, p. 897-909 13 p.

    Research output: Contribution to journalArticle

  25. Benefits and risks of pharmacotherapy for dysthymia - A systematic appraisal of the evidence

    De Lima, M. S. & Hotopf, M., 2003, In : Drug Safety. 26, 1, p. 55 - 64 10 p.

    Research output: Contribution to journalArticle

  26. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: Is this a class effect?

    Chaudhuri, K. R., Pal, S. & Brefel-Courbon, C., 2002, In : Drug Safety. 25, 7, p. 473-483 11 p.

    Research output: Contribution to journalArticle

  27. Nonsteroidal anti-inflammatory drugs and reversible female infertility - Is there a link?

    Stone, S., Khamashta, M. A. & Nelson-Piercy, C., 2002, In : Drug Safety. 25, 8, p. 545 - 551 7 p.

    Research output: Contribution to journalArticle

  28. Tolerability of atypical antipsychotics

    Stanniland, C. & Taylor, D., Mar 2000, In : Drug Safety. 22, 3, p. 195-214 20 p.

    Research output: Contribution to journalArticle

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454